PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023

Report Back from SGO 2023: What’s New in Ovarian Cancer?Подробнее

Standard of care updates in ovarian cancer: PARP inhibitorsПодробнее

Updates in PARP inhibition for ovarian cancerПодробнее

Ovarian Cancer Symposium 2021: Session 4 PARP InhibitorsПодробнее

PARP inhibitors as first-line maintenance therapy in ovarian cancerПодробнее

Report Back from SGO: What’s the Latest in Ovarian Cancer?Подробнее

PARP inhibitors and ovarian cancerПодробнее

Overcoming resistance to PARP inhibition in ovarian cancerПодробнее

PARP inhibitors for ovarian cancerПодробнее

Webinar: PARP Inhibitors and Ovarian CancerПодробнее

Dr. Crafton on the Impact of PARP Inhibitors in Recurrent Ovarian CancerПодробнее

PARP inhibitor rechallenging in ovarian cancerПодробнее

A Webinar on PARP Inhibitors in Epithelial Ovarian CancerПодробнее

Assessing the role of PARP inhibitors and immunotherapy in ovarian cancerПодробнее

Updates in Treatment of Ovarian Cancer: PARP InhibitorsПодробнее

Update on PARP inhibitors in Ovarian and Pancreatic CancerПодробнее

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel ApproachesПодробнее

An Overview of PARP Inhibitors in Ovarian CancerПодробнее

PARP Inhibitor Trial UpdatesПодробнее